Related Experiment Video
Updated: Jun 13, 2026
03:32
A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
Published on: April 12, 2019
Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces
Sotirios Zarogiannis1, Ioannis Psallidas, Chrissi Hatzoglou
1Department of Physiology, Medical School, University of Thessaly, and Department of Respiratory Medicine, University Hospital of Larissa, Mezourlo Hill, 41110, Larissa, Greece. szarog@med.uth.gr
The Journal of Physiological Sciences : JPS
|April 13, 2010
Summary
Dexamethasone treatment significantly accelerated pleural fluid absorption in mice with induced hydrothoraces. This finding suggests corticosteroids may aid in resolving pleural effusions in certain clinical cases.
Area of Science:
- Biomedical research
- Pharmacology
- Respiratory medicine
Background:
- Hydrothoraces, or pleural effusions, can result from various etiologies.
- Corticosteroids are sometimes used clinically to manage pleural effusions.
- The precise mechanism by which corticosteroids affect pleural fluid resolution is not fully understood.
Purpose of the Study:
- To investigate the effect of dexamethasone on the clearance of experimentally induced hydrothoraces in a mouse model.
- To determine if dexamethasone accelerates pleural fluid absorption.
Main Methods:
- Twenty-four C57BL/6 mice were used, with hydrothoraces induced via intrapleural injection of PBS-BSA.
- Mice were divided into control (PBS) and treatment (dexamethasone 1 mg/kg) groups.
- Pleural fluid volume and absorption rates were measured at 2 and 4 hours post-induction.
Main Results:
- Dexamethasone-treated mice showed significantly lower pleural fluid volumes at both 2 and 4 hours compared to controls.
- The rate of pleural fluid absorption was significantly higher in the dexamethasone-treated group.
- These results indicate dexamethasone enhances pleural fluid clearance.
Conclusions:
- Dexamethasone demonstrably accelerates pleural fluid absorption in isosmotic hydrothoraces in mice.
- This observed effect of dexamethasone may contribute to its clinical efficacy in managing certain types of pleural effusions.
- Further research could explore the molecular mechanisms underlying this accelerated fluid clearance.
Related Concept Videos
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations: